Physiological roles of matrix metalloproteinases: Implications for tumor growth and metastasis

Canadian Journal of Physiology and Pharmacology

Volumn 77, Issue 7, 1999, Pages 465-480

  Forget, Marie Annick ^a   Desrosiers, Richard R ^a   Béliveau, Richard ^a  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

Author keywords

Cancer; Cell invasion; Extracellular matrix; Matrix metalloproteinases; Physiology

Indexed keywords

COLLAGENASE; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; STROMELYSIN;

ALZHEIMER DISEASE; ANGIOGENESIS; CANCER INVASION; CARCINOGENESIS; CELL DIFFERENTIATION; CELL INFILTRATION; CELL PROLIFERATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; EXTRACELLULAR MATRIX; GROWTH REGULATION; HUMAN; METASTASIS POTENTIAL; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; TUMOR GROWTH;

EID: 0032709474     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y99-055     Document Type: Review

References (144)

1. Agren, M.S., Engel, M.A., and Mertz, P.M. 1994. Collagenase during burn wound healing: influence of a hydrogel dressing and pulsed electrical stimulation. Plast. Reconstr. Surg. 94: 518-524.
2. Basset, P., Wolf, C., Rouyer, N., Bellocq, J.P., Rio, M.C., and Chambon, P. 1994. Stromelysin-3 in stromal tissue as a control factor in breast cancer behavior. Cancer, 74(3 Suppl.): 1045-1049.
3. Beaulieu, E., Kachra, Z., Mousseau, N., Delbecchi, L., Hardy, J., and Béliveau, R. 1999. Matrix metalloproteinases and their inhibitors in human pituitary tumors. Neurosurgery. In press.
4. Benbow, U., and Brinckerhoff, C.E. 1997. The AP-1 site and MMP gene regulation: what is all the fuss about? Matrix Biol. 15: 515-526.
5. Bernhard, E.J., Gruber, S.B., and Muschel, R.J. 1994. Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells. Proc. Natl. Acad. Sci. U.S.A. 91: 4293-4297.
6. Birkedal-Hansen, H., Moore, W.G., Bodden, M.K., Windsor, L.J., Birkedal-Hansen, B., DeCarlo, A., and Engler, J.A. 1993. Matrix metalloproteinases: a review. Crit. Rev. Oral Biol. Med. 4: 197-250.
7. Blood, C.H., and Zetter, B.R. 1990. Tumor interactions with the vasculature: angiogenesis and tumor metastasis. Biochim. Biophys. Acta, 1032: 89-118.
8. Brinckerhoff, C.E. 1991. Joint destruction in arthritis: metalloproteinases in the spotlight. Arthritis Rheum. 34: 1073-1075.
9. Brooks, P.C., Strömblad, S., Sanders, L.C., von Schalscha, T.L., Aimes, R.T., Stetler-Stevenson, W.G., Quigley, J.P., and Cheresh, D.A. 1996. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin αvβ3. Cell, 85: 683-693.
10. Brooks, P.C., Silletti, S., von Schalscha, T.L., Friedlander, M., and Cheresh, D.A. 1998. Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity. Cell, 92: 391-400.
11. Brown, P.D., Levy, A.T., Margulies, I.M., Liotta, L.A., and Stetler-Stevenson, W.G. 1990. Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines. Cancer Res. 50: 6184-6191.
12. Carmeliet, P., Moons, L., Lijnen, R., Baes, M., Lemaitre, V., Tipping, P., Drew, A., Eeckhout, Y., Shapiro, S.D., Lupu, F., and Collen, D. 1997. Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation. Nat. Genet. 17: 439-444.
13. Chapman, D., Weber, K.T., and Eghbali, M. 1990. Regulation of fibrillar collagen types I and III and basement membrane type IV collagen gene expression in hypertrophied rat myocardium. Circ. Res. 67: 787-794.
14. Cheresh, D.A. 1998. Death to a blood vessel, death to a tumor. Nat. Med. 4: 395-396.
15. Collier, I.E., Brans, G.A.P., Goldberg, G.I., and Gerhard, D.S. 1991. On the structure and chromosome location of the 72- and 92-kDa human type IV collagenase genes. Genomics, 9: 429-434.
16. Corcoran, M.L., Hewitt, R.E., Kleiner, D.E., Jr., and Stetler-Stevenson, W.G. 1996. MMP-2: expression, activation and inhibition. Enzyme Protein, 49: 7-19.
17. Cossins, J., Dudgeon, T.J., Catlin, G., Gearing, A.J.H., and Clements, J.M. 1996. Identification of MMP-18, a putative novel human matrix metalloproteinase. Biochem. Biophys. Res. Commun. 228: 494-498.
18. Crawford, H.C., and Matrisian, L.M. 1996. Mechanisms controlling the transcription of matrix metalloproteinase genes in normal and neoplastic cells. Enzyme Protein, 49: 20-37.
19. Curry, T.E., Jr., Mann, J.S., Estes, R.S., and Jones P.B.C. 1990. Alpha2-macroglobulin and tissue inhibitor of metalloproteinases: collagenase inhibitors in human preovulatory ovaries. Endocrinology, 127: 63-68.
20. Cuzner, M.L., Gveric, D., Strand, C., Loughlin, A.J., Paemen, L., Opdenakker, G., and Newcombe, J. 1996. The expression of tissue-type plasminogen activator, matrix metalloproteases and endogenous inhibitors in the central nervous system in multiple sclerosis: comparison of stages in lesion evolution. J. Neuropathol. Exp. Neurol. 55: 1194-1204.
21. D'Armiento, J., Dalal, S.S., Okada, Y., Berg, R.A., and Chada, K. 1992. Collagenase expression in the lungs of transgenic mice causes pulmonary emphysema. Cell, 71: 955-961.
22. D'Armiento, J., DiColandrea, T., Dalal, S.S., Okada, Y., Huang, M.T., Conney, A.H., and Chada, K. 1995. Collagenase expression in transgenic mouse skin causes hyperkeratosis and acanthosis and increases susceptibility to tumorigenesis. Mol. Cell. Biol. 15: 5732-5739.
23. Dean, D.D., Martel-Pelletier, J., Pelletier, J.P., Howell, D.S., and Woessner, J.F., Jr. 1989. Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J. Clin. Invest. 84: 678-685.
24. Deb, S., and Gottschall, P.E. 1996. Increased production of matrix metalloproteinases in enriched astrocyte and mixed hippocampal cultures treated with beta-amyloid peptides. J. Neurochem. 66: 1641-1647.
25. DeClerck, Y.A., and Laug, W.E. 1996. Cooperation between matrix metalloproteinases and the plasminogen activator - plasmin system in tumor progression. Enzyme Protein, 49: 72-84.
26. DeClerck, Y.A., Perez, N., Shimada, H., Boone, T.C., Langley, K.E., and Taylor, S.M. 1992. Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res. 52: 701-708.
27. Delbecchi, L., Beaulieu, E., Mousseau, N., Moudjan, R., Del Maestro, X., and Béliveau, R. 1998. Expression of matrix metalloproteinases and their inhibitors in human brain tumors. Anti-cancer proteins and drugs: structure, function and design. N.Y. Acad. Sci. In press.
28. Den Besten, P.K., Punzi, J.S., and Li, W. 1998. Purification and sequencing of a 21 kDa and 25 kDa bovine enamel metalloproteinase. Eur. J. Oral Sci. 106(Suppl. 1): 345-349.
29. Deryugina, E.I., Bourbon, M.A., Luo, G.X., Reisfeld, R.A., and Strongin, A. 1997a. Matrix metalloproteinase-2 activation modulates glioma cell migration. J. Cell Sci. 110: 2473-2482.
30. Deryugina, E.I., Luo, G.X. Reisfeld, R.A., Bourdon, M.A., and Strongin, A. 1997b. Tumor cell invasion through matrigel is regulated by activated matrix metalloproteinase-2. Anticancer Res. 17: 3201-3210.
31. Deryugina, E.I., Reisfeld, R.A., Bourdon, M.A., and Strongin, A. 1998. Cell surface MT1-MMP and αvβ3 jointly govern the activation of MMP-2 proenzyme by human tumor cells. Proc. Am. Assoc. Cancer Res. 39: 82.
32. Di Colandrea, T., Wang, L., Wille, J., D'Armiento, J., and Chada, K.K. 1998. Epidermal expression of collagenase delays wound-healing intransgenic mice. J. Invest. Dermatol. 111: 1029-1033.
33. Dong, Z., Kumar, R., Yang, X., and Fidler, I.J. 1997. Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma. Cell, 88: 801-810.
34. d'Ortho, M.P., Will, H., Atkinson, S., Butler, G., Messent, A., Gavrilovic, J., Smith, B., Timpl, R., Zardi, L., and Murphy, G. 1997. Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases. Eur. J. Biochem. 250: 751-757.
35. Ellis, A.J., Curry, V.A., Powell, E.K., and Cawston, T.E. 1994. The prevention of collagen breakdown in bovine nasal cartilage by TIMP, TIMP-2 and a low molecular weight synthetic inhibitor. Biochem. Biophys. Res. Commun. 201: 94-101.
36. Engel, G., Heselmeyer, K., Auer, G., Bäckdahl, M., Eriksson, E., and Linder, S. 1994. Correlation between stromelysin-3 mRNA level and outcome of human breast cancer. Int. J. Cancer, 58: 830-835.
37. Flenniken, A.M., and Williams, B.R.G. 1990. Developmental expression of the endogenous TIMP gene and a TIMP-lacZ fusion gene in transgenic mice. Genes Dev. 4: 1094-1106.
38. Folkman, J., and Shing, Y. 1992. Angiogenesis. J. Biol. Chem. 267: 10931-10934.
39. Fridman, R., Fuerst, T.R., Birb, R.E., Hoyhtya, M., Oelkuct, M., Kraus, S., Komarek, D., Liotta, L.A., Berman, M.L., and Stetler-Stevenson, W.G. 1992. Domain structure of human 72-kDa gelatinase/type IV collagenase. Characterization of proteolytic activity and identification of the tissue inhibitor of metalloproteinase-2 (TIMP-2) binding regions. J. Biol. Chem. 267: 15398-15405.
40. Funck, R.C., Wilke, A., Rupp, H., and Brilla, C.G. 1997. Regulation and role of myocardial collagen matrix remodelling in hypertensive heart disease. Adv. Exp. Med. Biol. 432: 35-44.
41. Gingras, D., and Béliveau, R. 1997. L'angiogenèse tumorale: une nouvelle cible thérapeutique anticancéreuse. M/S, 13: 1428-1435.
42. Gomez, D.E., Alonso, D.F., Yoshiji, H., and Thorgeirsson, U.P. 1997. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur. J. Cell Biol. 74: 111-122.
43. Greene, J., Wang, M., Liu, Y.E., Raymond, L.A., Rosen, C., and Shi, Y.E. 1996. Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4. J. Biol. Chem. 271: 30375-30380.
44. Gururajan, R., Grenet, J., Lahti, J.M., and Kidd, V.J. 1998. Isolation and characterization of two novel metalloproteinase genes linked to the Cdc2L locus on human chromosome 1p36.3. Genomics, 15: 101-106.
45. Hautamaki, R.D., Kobayashi, D.K., Senior, R.M., and Shapiro, S.D. 1997. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science (Washington, D.C.), 277: 2002-2004.
46. Hayakawa, T., Yamashita, K., Tanzawa, K., Uchijima, E., and Iwata, K. 1992. Growth-promoting activity of tissue inhibitor of metalloproteinase-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum. FEBS Lett. 298: 29-32.
47. Hayakawa, T., Yamashita, K., Ohuchi, E., and Shinagawa, A. 1994. Cell growth-promoting activity of tissue inhibitor of metalloproteinase-2 (TIMP-2). J. Cell Sci. 107: 2373-2379.
48. Hill, P.A., Reynolds, J.J., and Meikle, M.C. 1993. Inhibition of stimulated bone resorption in vitro by TIMP-1 and TIMP-2. Biochim. Biophys. Acta, 1177: 71-74.
49. Hill, P.A., Murphy, G., Docherty, A.J., Hembry, R.M., Millican, T.A., Reynolds, J.J., and Meikle, M.C. 1994. The effects of selective inhibitors of matrix metalloproteinases (MMPs) on bone resorption and the identification of MMPs and TIMP-1 in isolated osteoclasts. J. Cell Sci. 107: 3055-3064.
50. Hirose, T., Patterson, C., Pourmotabbed, T., Mainardi, C.L., and Hasty, K.A. 1993. Structure-function relationship of human neutrophil collagenase: identification of regions responsible for substrate specificity and general proteinase activity. Proc. Natl. Acad. Sci. U.S.A. 90: 2569-2573.
51. Howard, E.W., Bullen, E.C., and Banda, M.J. 1991. Regulation of the autoactivation of human 72-kDa progelatinase by tissue inhibitor of metalloproteinase-2. J. Biol. Chem. 266: 13064-13069.
52. Imai, K., Ohuchi, E., Aoki, T., Nomura, H., Fujii, Y., Sato, H., Seiki, M., and Okada, Y. 1996. Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinase 2. Cancer Res. 56: 2707-2710.
53. Itoh, T., Tanioka, M., Yoshida, H., Yoshioka, T., Nishimoto, H., and Itohara, S. 1998. Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res. 58: 1048-1051.
54. Jones, P.A., and DeClerck, Y.A. 1980. Destruction of extracellular matrices containing glycoproteins, elastin and collagen by metastatic human tumor cells. Cancer Res. 40: 3222-3227.
55. Khokha, R., Waterhouse, P., Yagel, S., Lala, P.K., Overall, C.M., Norton, G., and Denhardt, D.T. 1989. Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells. Science (Washington, D.C.), 243: 947-950.
56. Khokha, R., Zimmer, M.J., Graham, C.H., Lala, P.K., and Waterhouse, P. 1992. Suppression of invasion by inducible expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in B16-F10 melanoma cells. J. Natl. Cancer Inst. 84: 1017-1022.
57. Knäuper, V., Will, H., López-Otin, C., Smith, B., Atkinson, S.J., Stanton, H., Hembry, R.M., and Murphy, G. 1996. Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase A (MMP-2) are able to generate active enzyme. J. Biol. Chem. 271: 17124-17131.
58. Kruger, A., Sanchez-Sweatman, O.H., Martin, D.C., Fata, J.E., Ho, A.T., Orr, F.W., Ruther, U., and Khokha, R. 1998. Host TIMP-1 overexpression confers resistance to experimental brain metastasis of a fibrosarcoma cell line. Oncogene, 16: 2419-2423.
59. Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London), 227: 680-685.
60. Lantz, M.S., and Ciborowski, P. 1994. Zymographic techniques for detection and characterization of microbial proteases. Methods Enzymol. 235: 563-594.
61. Leco, K.J., Khokha, R., Pavloff, N., Hawkes, S.P., and Edwards, D.R. 1994. Tissue inhibitor of metalloproteinase-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. J. Biol. Chem. 269: 9352-9360.
62. LePage, R.N., Fosang, A.J., Fuller, S.J., Murphy, G., Evin, G., Beyreuther, K., Masters, C.L., and Small, D.H. 1995. Gelatinase A possesses a beta-secretase-like activity in cleaving the amyloid protein precursor of Alzheimer's disease. FEBS Lett. 377: 267-270.
63. Librach, C.L., Werb, Z., Fitzgerald, M.L., Chiu, K., Corwin, N.M., Esteves, R.A., Grobelny, D., Galardy, R., Damsky, C.H., and Fisher, S.J. 1991. 92-kD type IV collagenase mediates invasion of human cytotrophoblasts. J. Cell Biol. 113: 437-449.
64. Llano, E., Pendás, A.M., Knäuper, V., Sorsa, T., Salo, T., Salido, E., Murphy, G., Simmer, J.P., Bartlett, J.D., and López-Otín, C. 1997. Identification and structural and functional characterization of human enamelysin (MMP-20). Biochemistry, 36: 15101-15108.
65. Lund, L.R., Romer, J., Thomasset, N., Solberg, H., Pyke, C., Bissell, M.J., Dano, K., and Werb, Z. 1996. Two distinct phases of apoptosis in mammary gland involution: proteinase-independent and -dependent pathways. Development, 122: 181-193.
66. MacDougall, J.R., and Matrisian, L.M. 1995. Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Metastasis Rev. 14: 351-362.
67. MacNaul, K.L., Chartrain, N., Lark, M., Tocci, M.J., and Hutchinson, N.I. 1990. Discoordinate expression of stromelysin, collagenase, and tissue inhibitor of metalloproteinase-1 in rheumatoid human synovial fibroblasts. Synergistic effects of interleukin-1 and tumor necrosis factor-α on stromelysin expression. J. Biol. Chem. 265: 17238-17245.
68. Maeda, A., and Sobel, R.A. 1996. Matrix metalloproteinases in the normal human central nervous system, microglial nodules, and multiple sclerosis lesions. J. Neuropathol. Exp. Neurol. 55: 300-309.
69. Masson, R., Lefebvre, O., Noel, A., Fahime, M.E., Chenard, M.P., Wendling, C., Kebers, F., LeMeur, M., Dierich, A., Foidart, J.M., Basset, P., and Rio, M.C. 1998. In vivo evidence that the stromelysin-3 metalloproteinase contributes in a paracrine manner to epithelial cell malignancy. J. Cell Biol. 140: 1535-1541.
70. Massova, I., Kotra, L.P., Fridman, R., and Mobashery, S. 1998. Matrix metalloproteinases: structures, evolution and diversification. FASEB J. 12: 1075-1095.
71. Matrisian, L.M. 1992. The matrix-degrading metalloproteinases. Bioessays, 14: 455-463.
72. McCachren, S.S. 1991. Expression of metalloproteinases and metalloproteinase inhibitor in human arthritic synovium. Arthritis Rheum. 34: 1085-1093.
73. Mignatti, P., and Rifkin, D.B. 1993. Biology and biochemistry of proteinases in tumor invasion. Physiol. Rev. 73: 161-195.
74. Mignatti, P., and Rifkin, D.B. 1996. Plasminogen activators and matrix metalloproteinases in angiogenesis. Enzyme Protein, 49: 117-137.
75. Mignatti, P., Tsuboi, R., Robbins, E., and Rifkin, D.B. 1989. In vitro angiogenesis on the human amniotic membrane: requirements for basic fibroblast growth factor-induced proteinases. J. Cell Biol. 108: 671-682.
76. Mignon, C., Okada, A., Mattei, M.G., and Basset, P. 1995. Assignment of the human membrane-type matrix metalloproteinase (MMP14) gene to 14q11-q12 by in situ hybridization. Genomics, 28: 360-361.
77. Miyazaki, K., Hasegawa, M., Funahashi, K., and Umeda, M. 1993. A metalloproteinase inhibitor domain in Alzheimer amyloid protein precursor. Nature (London), 362: 839-841.
78. Mohanam, S., Wang, S.W., Rayford, A., Yamamoto, M., Sawaya, R., Nakajima, M., Liotta, L.A., Nicolson, G.L., Stetler-Stevenson, W.G., and Rao, J.S. 1995. Clin. Exp. Metastasis, 13: 57-62.
79. Montgomery, A.M., DeClerck, Y.A., Langley, K.E., Reisfeld, R.A., and Mueller, B.M. 1993. Melanoma-mediated dissolution of extracellular matrix: contribution of urokinase-dependant and metalloproteinase-dependant proteolytic pathways. Cancer Res. 53: 693-700.
80. Mueller, B.M., Yu, Y.B., and Laug, W.E. 1995. Overexpression of plasminogen activator inhibitor 2 in human melanoma cells inhibits spontaneous metastasis in scid/scid mice. Proc. Natl. Acad. Sci. U.S.A. 92: 205-209.
81. Murphy, A.N., Unsworth, E.J., and Stetler-Stevenson, W.G. 1993. Tissue inhibitor of metalloproteinase-2 inhibits bFGF-induced human microvascular endothelial cell proliferation. J. Cell. Physiol. 157: 351-358.
82. Nerlov, C., Rorth, P., Blasi, F., and Johnsen, M. 1991. Essential AP-1 and PEA3 binding elements in the human urokinase enhancer display cell type-specific activity. Oncogene, 6: 1583-1592.
83. Nguyen, M., Arkell, J., and Jackson, C.J. 1998. Active and tissue inhibitor of matrix metalloproteinase-free gelatinase B accumulates within human microvascular endothelial vesicles. J. Biol. Chem. 273: 5400-5404.
84. Nomura, K., Tanaka, H., Kikkawa, Y., Yamaguchi, M., and Suzuki, N. 1991. The specificity of sea urchin hatching enzyme (envelysin) places it in the mammalian matrix metalloproteinase family. Biochemistry, 30: 6115-6123.
85. Nomura, K., Shimizu, T., Kinoh, H., Sendai, Y., Inomata, M., and Suzuki, N. 1997. Sea urchin hatching enzyme (envelysin): cDNA cloning and deprivation of protein substrate specificity by autolytic degradation. Biochemistry, 36: 7225-7238.
86. O'Hagan, R.C., Tozer, R.G., Symons, M., McCormick, F., and Kassel, J.A. 1996. The activity of the Ets transcription factor PEA3 is regulated by two distinct MAPK cascades. Oncogene, 13: 1323-1333.
87. Ohuchi, E., Imai, K., Fujii, Y., Sato, H., Seiki, M., and Okada, Y. 1997. Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J. Biol. Chem. 272: 2446-2451.
88. Oikarinen, A., Kylmaniemi, M., Autio-Harmainen, H., Autio, P., and Salo, T. 1993. Demonstration of 72-kDa and 92-kDa forms of type IV collagenase in human skin: variable expression in various blistering diseases, induction during re-epithelialization, and decrease by topical glucocorticoids. J. Invest. Dermatol. 101: 205-210.
89. Okumura, Y., Sato, H., Seiki, M., and Kido, H. 1997. Proteolytic activation of the precursor of membrane type 1 matrix metalloproteinase by human plasmin. A possible cell surface activator. FEBS Lett. 402: 181-184.
90. Olson, T.M., Hirohata, S., Ye, J., Leco, K., Seldin, M.F., and Apte, S.S. 1998. Cloning of the human tissue inhibitor of metalloproteinase-4 gene (TIMP4) and localization of the TIMP4 and Timp4 genes to human chromosome 3p25 and mouse chromosome 6, respectively. Genomics, 51: 148-151.
91. Opdenakker, G., and Van Damme, J. 1994. Cytokine-regulated proteases in autoimmune diseases. Immunol. Today, 15: 103-107.
92. Pei, D., and Weiss, S.J. 1995. Furin-dependent intracellular activation of the human stromelysin-3 zymogen. Nature (London), 375: 244-247.
93. Pendas, A.M., Matilla, T., Estivill, X., and Lopez-Otin, C. 1995. The human collagenase-3 (CLG3) gene is located on chromosome 11q22.3 clustered to other members of the matrix metalloproteinase gene family. Genomics, 26: 615-618.
94. Pendas, A.M., Santamaria, I., Alvarez, M.V., Pritchard, M., and Lopez-Otin, C. 1996. Fine physical mapping of the human matrix metalloproteinase genes clustered on chromosome 11q22.3. Genomics, 37: 266-268.
95. Pendas, A.M., Knäuper, V., Puente, X.S., Llano, E., Mattei, M.G., Apte, S., Murphy, G., and Lopez-Otin, C. 1997. Identification and characterization of a novel human matrix metalloproteinase with unique structural characteristics, chromosomal location, and tissue distribution. J. Biol. Chem. 272: 4281-4286.
96. Powell, W.C., and Matrisian, L.M. 1996. Complex roles of matrix metalloproteinases in tumor progression. Curr. Top. Microbiol. Immunol. 213: 1-21.
97. Powell, W.C., Knox, J.D., Navre, M., Grogan, T.M., Kittelson, J., Nagle, R.B., and Bowden, G.T. 1993. Expression of the metalloproteinase matrilysin in DU-145 cells increases their invasive potential in severe combined immunodeficient mice. Cancer Res. 53: 417-422.
98. Puente, X.S., Pendas, A.M., Llano, E., and Lopez-Otin, C. 1998. Localization of the human membrane type 4-matrix metalloproteinase gene (MMP17) to chromosome 12q24. Genomics, 54: 578-579.
99. Rao, J.S., Yamamoto, M., Mohaman, S., Gokaslan, Z.L., Fuller, G.N., Stetler-Stevenson, W.G., Rao, V.H., Liotta, L.A., Nicolson, G.L., and Sawaya, R.E. 1996. Expression and localization of 92 kDa type IV collagenase/gelatinase B (MMP-9) in human gliomas. Clin. Exp. Metastasis, 14: 12-18.
100. Rechberger, T., and Woessner, J.F., Jr. 1993. Collagenase, its inhibitors, and decorin in the lower uterine segment in pregnant women. Am. J. Obstet. Gynecol. 168: 1598-1603.
101. Rodgers, W.H., Osteen, K.G., Matrisian, L.M., Navre, M., Giudice, L.C., and Gorstein, F. 1993. Expression and localization of matrilysin, a matrix metalloproteinase, in human endometrium during the reproductive cycle. Am. J. Obstet. Gynecol. 168: 253-260.
102. Rosenberg, G.A. 1995. Matrix metalloproteinases in brain injury. J. Neurotrauma, 12: 833-842.
103. Rosenberg, G.A., and Navratil, M. 1997. Metalloproteinase inhibition blocks edema in intracerebral hemorrhage in the rat. Neurology, 48: 921-926.
104. Rudolph-Owen, L.A., Hulboy, D.L., Wilson, C.L., Mudgett, J., and Matrisian, L.M. 1997. Coordinate expression of matrix metalloproteinase family members in the uterus of normal, matrilysin-deficient, and stromelysin-1-deficient mice. Endocrinology, 138: 4902-4911.
105. Sato, H., Okada, Y., and Seiki, M. 1997a. Membrane-type matrix metalloproteinases (MT-MMPs) in cell invasion. Thromb. Haemostasis, 78: 497-500.
106. Sato, H., Tanaka, M., Takino, T., Inoue, M., and Seiki, M. 1997b. Assignment of the human genes for membrane-type-1, -2, and -3 matrix metalloproteinases (MMP14, MMP15 and MMP16) to 14q12.2, 16q12.2-q21, and 8q21, respectively by in situ hybridization. Genomics, 39: 412-413.
107. Schnaper, H.W., Grant, D.S., Stetler-Stevenson, W.G., Fridman, R., D'Orazi, G., Murphy, A.N., Bird, R.E., Hoythya, M., Fuerst, T.R., French, D.L., Quigley, J.P., and Kleinmann, H.K. 1993. Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro. J. Cell. Physiol. 156: 235-246.
108. Schultz, R.M., Silberman, S., Persky, B., Bajkowski, A.S., and Carmichael, D.F. 1988. Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16-F10 melanoma cells. Cancer Res. 48: 5539-5545.
109. Seiki, M. 1996. Membrane type-matrix metalloproteinase and tumor invasion. Curr. Top. Microbiol. Immunol. 213: 23-32.
110. Shapiro, S.D. 1997. Mighty mice: transgenic technology "knocks out" questions of matrix metalloproteinase function. Matrix Biol. 15: 527-533.
111. Shapiro, S.D. 1998. Matrix metalloproteinase degradation of extracellular matrix: biological consequences. Curr. Opin. Cell Biol. 10: 602-608.
112. Shipley, J.M., Doyle, G.A., Fliszar, C.J., Ye, Q.Z., Johnson, L.L., Shapiro S.D., Welgus, H.G., and Senior, R.M. 1996. The structural basis for the elastolytic activity of the 92-kDa and 72-kDa gelatinases. Role of the fibronectin type II-like repeats. J. Biol. Chem. 271: 4335-4341.
113. Soloway, P.D., Alexander, C.M., Werb, Z., and Jaenisch, R. 1996. Targeted mutagenesis of Timp-1 reveals that lung tumor invasion is influenced by Timp-1 genotype of the tumor but not by that of the host. Oncogene, 13: 2307-2314.
114. Springman, E.B., Angleton, E.L., Birkedal-Hansen, H., and Van Wart, H.E. 1990. Multiple modes of activation of latent human fibroblast collagenase: evidence for the role of a Cys73 activesite zinc complex in latency and a "cysteine-switch" mechanism for activation. Proc. Natl. Acad. Sci. U.S.A. 87: 364-368.
115. Stetler-Stevenson, W.G., Aznavoorian, S., and Liotta, L.A. 1993a. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu. Rev. Cell Biol. 9: 541-573.
116. Stetler-Stevenson, W.G., Liotta, L.A., and Kleiner, D.E., Jr. 1993b. Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J. 7: 1434-1441.
117. Stolow, M.A., Bauzon, D.D., Li, J., Sedgwick, T., Liang, V.C.T., Sang, Q.A., and Shi, Y.B. 1996. Identification and characterization of a novel collagenase in Xenopus laevis: possible roles during frog development. Mol. Biol. Cell, 7: 1471-1483.
118. Stricklin, G.P., and Welgus, H.G. 1983. Human skin fibroblast collagenase inhibitor. Purification and biochemical characterization. J. Biol. Chem. 258: 12252-12258.
119. Strongin, A.Y., Marmer, B.L., Grant, G.A., and Goldberg, G.I. 1993. Plasma membrane-dependant activation of the 72-kDa type IV collagenase is prevented by complex formation with TIMP-2. J. Biol. Chem. 268: 14033-14039.
120. Sugiura, Y., Shimada, H., Seeger, R.C., Laug, W.E., and DeClerck, Y.A. 1998. Matrix metalloproteinases-2 and -9 are expressed in human neuroblastoma: contribution of stromal cells to their production and correlation with metastasis. Cancer Res. 58: 2209-2216.
121. Sympson, C.J., Bissel, M.J., and Werb, Z. 1995. Mammary gland tumor formation in transgenic mice overexpressing stromelysin-1. Semin. Cancer Biol. 6: 159-163.
122. Talhouk, R.S., Bissell, M.J., and Werb, Z. 1992. Coordinated expression of extracellular matrix-degrading proteinases and their inhibitors regulates mammary epithelial function during involution. J. Cell Biol. 118: 1271-1282.
123. Taraboletti, G., Garofalo, A., Belotti, D., Drudis, T., Borsotti, P., Scanziani, E., Brown, P.D., and Giavazzi, R. 1995. Inhibition of angiogenesis and murine hemangioma growth by batimastat, a synthetic inhibitor of matrix metalloproteinases. J. Natl. Cancer Inst. 87: 293-298.
124. Tarlton, J.F., Vickery, C.J., Leaper, D.J., and Bailey, A.J. 1997. Postsurgical wound progression monitored by temporal changes in the expression of matrix metalloproteinase-9. Br. J. Dermatol. 137: 506-516.
125. Taylor, K.B., Windsor, L.J., Caterina, N.C.M., Bodden, M.K., and Engler, J.A. 1996. The mechanism of inhibition of collagenase by TIMP-1. J. Biol. Chem. 271: 23938-23945.
126. Uhm, J.H., Dooley, N.P., Villemure, J.G., and Yong, V.W. 1996. Glioma invasion in vitro: regulation by matrix metalloprotease-2 and protein kinase C. Clin. Exp. Metastasis, 14: 421-433.
127. Van Aelst, L., and D'Souza-Schorey, C. 1997. Rho GTPases and signaling networks. Genes Dev. 11: 2295-2322.
128. Vu, T.H., Shipley, J.M., Bergers, G., Berger, J.E., Helms, J.A., Hanahan, D., Shapiro, S.D., Senior, R.M., and Werb, Z. 1998. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell, 93: 411-422.
129. Wang, M., Liu, Y.E., Greene, J., Sheng, S., Fuchs, A., Rosen, E.M., and Shi, Y.E. 1997. Inhibition of tumor growth and metastasis of human breast cancer cells transfected with tissue inhibitor of metalloproteinase 4. Oncogene, 14: 2767-2774.
130. Wilhelm, S.M., Eisen, A.Z., Teter, M., Clark, S.D., Kronberger, A., and Goldberg, G. 1986. Human fibroblast collagenase: glycosylation and tissue-specific level of enzyme synthesis. Proc. Natl. Acad. Sci. U.S.A. 83: 3756-3760.
131. Wilhelm, S.M., Collier, I.E., Kronberger, A., Eisen, A.Z., Marmer, B.L., Grant, G.A., Bauer, E.A., and Goldberg, G.I. 1987. Human skin fibroblast stromelysin: structure, glycosylation, substrate specificity and differential expression in normal and tumorigenic cells. Proc. Natl. Acad. Sci. U.S.A. 84: 6725-6729.
132. Wilson, C.L., and Matrisian, L.M. 1996. Matrilysin, an epithelial matrix metalloproteinase with potentially novel functions. Int. J. Biochem. Cell Biol. 28: 123-136.
133. Wilson, C.L., Heppner, K.J., Labosky, P.A., Hogan, B.L., and Matrisian, L.M. 1997. Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. Proc. Natl. Acad. Sci. U.S.A. 94: 1402-1407.
134. Witty, J.P., McDonnell, S., Newell, K.J., Cannon, P., Navre, M., Tressler, R.J., and Matrisian, L.M. 1994. Modulation of matrilysin levels in colon carcinoma cell lines affects tumorigenicity in vivo. Cancer Res. 54: 4805-4812.
135. Witty, J.P., Lempka, T., Coffey, R.J., Jr., and Matrisian, L.M. 1995a. Decreased tumor formation in 7,12-dimethylbenz-anthracene-treated stromelysin-1 transgenic mice is associated with alterations in mammary epithelial cell apoptosis. Cancer Res. 55: 1401-1406.
136. Witty, J.P., Wright, J.H., and Matrisian, L.M. 1995b. Matrix metalloproteinases are expressed during ductal and alveolar mammary morphogenesis, and misregulation of stromelysin-1 in transgenic mice induces unscheduled alveolar development. Mol. Biol. Cell, 6: 1287-1303.
137. Woessner, J.F., Jr., and Taplin, C.J. 1988. Purification and properties of a small latent matrix metalloproteinase of the rat uterus. J. Biol. Chem. 263: 16918-16925.
138. Wysocki, A.B., Staiano-Coico, L., and Grinnel, F. 1993. Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. J. Invest. Dermatol. 101: 64-68.
139. Yamamoto, M., Mohanam, S., Sawaya, R., Fuller, G.N., Seiki, M., Sato, H., Gokaslan, Z.L., Liotta, L.A., Nicolson, G.L., and Rao, J.S. 1996. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro. Cancer Res. 56: 384-392.
140. Yang, M., and Kurkinen, M. 1998. Cloning and characterization of a novel matrix metalloproteinase (MMP), CMMP, from chicken embryo fibroblasts. CMMP, Xenopus XMMP, and human MMP19 have a conserved unique cysteine in the catalytic domain. J. Biol. Chem. 273: 17893-17900.
141. Yang, M., Murray, M.T., and Kurkinen, M. 1997. A novel matrix metalloproteinase gene (XMMP) encoding vitronectin-like motifs is transiently expressed in Xenopus laevis early embryo development. J. Biol. Chem. 272: 13527-13533.
142. Yong, V.W., Krekoski, C.A., Forsyth, P.A., Bell, R., and Edwards, D.R. 1998. Matrix metalloproteinases and diseases of the CNS. Trends Neurosci. 21: 75-80.
143. Young, P.K., and Grinnel, F. 1994. Metalloproteinase activation cascade after burn injury: a longitudinal analysis of the human wound environment. J. Invest. Dermatol. 103: 660-664.
144. Zucker, S., Drews, M., Conner, C., Foda, H.D., DeClerck, Y.A., Langley, K.E., Bahou, W.F., Docherty, A.J.P., and Cao, J. 1998. Tissue inhibitor of metalloproteinase-2 (TIMP-2) binds to the catalytic domain of the cell surface receptor, membrane type 1-matrix metalloproteinase 1 (MT1-MMP). J. Biol. Chem. 273: 1216-1222.